> top > docs > PMC:7324763 > spans > 72982-73115 > annotations

PMC:7324763 / 72982-73115 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1167 0-4 PR:000009196 denotes Jak1
T1168 7-17 CHEBI:35222;CHEBI:35222 denotes inhibitors
T1169 80-88 SP_7 denotes COVID-19
T1170 107-118 DG_41 denotes baricitinib
T91493 0-4 PR:000009196 denotes Jak1
T58584 7-17 CHEBI:35222;CHEBI:35222 denotes inhibitors
T50670 80-88 SP_7 denotes COVID-19
T22229 107-118 DG_41 denotes baricitinib

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T503 80-88 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4327 7-17 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2037 0-6 Gene denotes Jak1/2 Gene:3716
2039 89-97 Species denotes patients Tax:9606
2042 107-118 Chemical denotes baricitinib MESH:C000596027
2044 80-88 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T440 0-133 Sentence denotes Jak1/2 inhibitors (JAKi) are also undergoing clinical trials in moderate-severe COVID-19 patients, such as baricitinib (NCT04320277).